Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission

B. Suberviola, A. Castellanos-Ortega, A. Ruiz Ruiz, M. Lopez-Hoyos, M. Santibañez



The soluble form of the urokinase-type plasminogen activator receptor (suPAR) and proadrenomedullin (proADM) are two new and promising sepsis biomarkers. We assessed the prognostic value of a single determination of proADM and suPAR, comparing them with C-reactive protein (CRP) and procalcitonin (PCT), and evaluating whether their addition to severity scores (APACHE II and SOFA) could improve their prognostic accuracy.


A single-centre prospective observational study conducted in an adult intensive care department at Marques de Valdecilla University Hospital in Spain. APACHE II and SOFA scores, CRP, PCT, suPAR ….

Leer mas en